OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e113-e124
Open Access | Times Cited: 31
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e113-e124
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1036-1043
Open Access | Times Cited: 39
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1036-1043
Open Access | Times Cited: 39
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study
Parikshit Sen, R Naveen, Arvind Nune, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 1, pp. 65-76
Open Access | Times Cited: 28
Parikshit Sen, R Naveen, Arvind Nune, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 1, pp. 65-76
Open Access | Times Cited: 28
Effect of DMARDs on the immunogenicity of vaccines
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 18
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 18
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis
Ana Cristina de Medeiros Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 710-719
Open Access | Times Cited: 23
Ana Cristina de Medeiros Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 710-719
Open Access | Times Cited: 23
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 10
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 10
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine
Ngai Sze Wong, Bonnie C.K. Wong, Jacky Man Chun Chan, et al.
AIDS (2022) Vol. 36, Iss. 9, pp. 1255-1264
Open Access | Times Cited: 13
Ngai Sze Wong, Bonnie C.K. Wong, Jacky Man Chun Chan, et al.
AIDS (2022) Vol. 36, Iss. 9, pp. 1255-1264
Open Access | Times Cited: 13
Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions
Chunmei Li, Hanfang Bi, Zhenwang Fu, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 12
Chunmei Li, Hanfang Bi, Zhenwang Fu, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 12
COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)—A Systematic Review of Study Designs and Methods
Malede Mequanent Sisay, Camila Montesinos‐Guevara, Alhadi Khogali Osman, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 6
Malede Mequanent Sisay, Camila Montesinos‐Guevara, Alhadi Khogali Osman, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 6
Immunogenicity of COVID ‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta‐analysis
Maysoon Al‐Haideri, Talar Ahmad Merza Mohammad, Shahram Darvishzadehdeldari, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 7, pp. 1227-1234
Closed Access | Times Cited: 5
Maysoon Al‐Haideri, Talar Ahmad Merza Mohammad, Shahram Darvishzadehdeldari, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 7, pp. 1227-1234
Closed Access | Times Cited: 5
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
Clóvis A. Silva, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Clóvis A. Silva, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Risk of waning humoral responses after inactivated or subunit recombinant SARS‐CoV‐2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China
Hu Li, Dachuan Cai, Depeng Jiang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 6
Hu Li, Dachuan Cai, Depeng Jiang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 6
Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions: a retrospective study
Chunmei Li, Ao Li, Hanfang Bi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Chunmei Li, Ao Li, Hanfang Bi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
A single‐center COVID ‐19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients
Serdar Can Güven, Özlem Karakaş, Ebru Atalar, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 7, pp. 787-794
Open Access | Times Cited: 4
Serdar Can Güven, Özlem Karakaş, Ebru Atalar, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 7, pp. 787-794
Open Access | Times Cited: 4
COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
Bruno Gualano, Carla Gonçalves Schahin Saad, Sofia Mendes Sieczkowska, et al.
Journal of Applied Physiology (2022) Vol. 132, Iss. 3, pp. 682-688
Open Access | Times Cited: 3
Bruno Gualano, Carla Gonçalves Schahin Saad, Sofia Mendes Sieczkowska, et al.
Journal of Applied Physiology (2022) Vol. 132, Iss. 3, pp. 682-688
Open Access | Times Cited: 3
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Rosa Maria Rodrigues Pereira, Marilia Ambiel Dagostin, Valéria F. Caparbo, et al.
Clinics (2022) Vol. 78, pp. 100150-100150
Open Access | Times Cited: 3
Rosa Maria Rodrigues Pereira, Marilia Ambiel Dagostin, Valéria F. Caparbo, et al.
Clinics (2022) Vol. 78, pp. 100150-100150
Open Access | Times Cited: 3
Safety and Immunogenicity of 3 Doses of BNT162b2 and CoronaVac in Children and Adults with Inborn Errors of Immunity
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 2
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 2
Immunogenicity and Safety of the Coronavac Inactivated SARS-CoV-2 Vaccine in People with Underlying Medical Conditions: A Retrospective Study
Chunmei Li, Hanfang Bi, Zhenwang Fu, et al.
SSRN Electronic Journal (2022)
Open Access | Times Cited: 2
Chunmei Li, Hanfang Bi, Zhenwang Fu, et al.
SSRN Electronic Journal (2022)
Open Access | Times Cited: 2
Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
Xingsu Gao, Fengcai Zhu
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e77-e78
Open Access | Times Cited: 2
Xingsu Gao, Fengcai Zhu
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e77-e78
Open Access | Times Cited: 2
Angiotensin converting enzyme 2 (ACE2): Virus accomplice or host defender
Jiyan Wang, Hongkai Chang, Yaya Qiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Jiyan Wang, Hongkai Chang, Yaya Qiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases
Bruno Gualano, Sofia Mendes Sieczkowska, Ítalo Ribeiro Lemes, et al.
Journal of Physical Activity and Health (2023) Vol. 20, Iss. 4, pp. 311-316
Open Access
Bruno Gualano, Sofia Mendes Sieczkowska, Ítalo Ribeiro Lemes, et al.
Journal of Physical Activity and Health (2023) Vol. 20, Iss. 4, pp. 311-316
Open Access
Angiotensin-converting enzyme 2: virus accomplice or host defender?
Jiyan Wang, Hongkai Chang, Yaya Qiao, et al.
Journal of Bio-X Research (2023) Vol. 06, Iss. 03, pp. 93-103
Open Access
Jiyan Wang, Hongkai Chang, Yaya Qiao, et al.
Journal of Bio-X Research (2023) Vol. 06, Iss. 03, pp. 93-103
Open Access
Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort study
Wei Zheng, Xiaoxia Cao, Jing Luo, et al.
Neurological Sciences (2023) Vol. 45, Iss. 4, pp. 1707-1717
Closed Access
Wei Zheng, Xiaoxia Cao, Jing Luo, et al.
Neurological Sciences (2023) Vol. 45, Iss. 4, pp. 1707-1717
Closed Access
08 Are DOACs dead? Or do they still have a role in SLE/APS?
David Isenberg
Abstracts (2022), pp. A4.2-A5
Open Access
David Isenberg
Abstracts (2022), pp. A4.2-A5
Open Access
